Bicocca Open Archive

Logo unimib boa
CAIROLI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.570
AS - Asia 3.194
NA - Nord America 2.665
SA - Sud America 130
AF - Africa 28
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.601
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.610
HK - Hong Kong 1.365
SG - Singapore 1.172
IT - Italia 958
RU - Federazione Russa 943
IE - Irlanda 896
CN - Cina 300
DE - Germania 191
ID - Indonesia 175
SE - Svezia 115
BR - Brasile 111
GB - Regno Unito 105
NL - Olanda 65
FI - Finlandia 62
IN - India 61
AT - Austria 53
ES - Italia 39
CA - Canada 28
FR - Francia 28
JP - Giappone 22
UA - Ucraina 22
MX - Messico 21
CH - Svizzera 18
TR - Turchia 15
AU - Australia 12
PH - Filippine 12
VN - Vietnam 12
BE - Belgio 11
DK - Danimarca 9
CZ - Repubblica Ceca 8
SA - Arabia Saudita 8
HR - Croazia 7
HU - Ungheria 7
KR - Corea 7
TN - Tunisia 7
CL - Cile 6
CO - Colombia 6
GR - Grecia 6
IL - Israele 6
MA - Marocco 6
NP - Nepal 6
PL - Polonia 6
TW - Taiwan 6
EG - Egitto 5
IR - Iran 5
RO - Romania 4
TH - Thailandia 4
ZA - Sudafrica 4
AR - Argentina 3
AZ - Azerbaigian 3
BD - Bangladesh 3
JO - Giordania 3
NO - Norvegia 3
PK - Pakistan 3
PT - Portogallo 3
AM - Armenia 2
BG - Bulgaria 2
LT - Lituania 2
RS - Serbia 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
UG - Uganda 2
UZ - Uzbekistan 2
AO - Angola 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
GH - Ghana 1
GT - Guatemala 1
KE - Kenya 1
LV - Lettonia 1
LY - Libia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
VE - Venezuela 1
Totale 9.601
Salva come PNG Salva come JPEG
Città #
Hong Kong 1.361
Dublin 845
Singapore 825
Santa Clara 402
New York 391
Milan 260
Ashburn 186
Jakarta 171
Ann Arbor 124
Beijing 115
Turin 88
Frankfurt am Main 76
Nuremberg 72
Seattle 59
Shanghai 51
Fairfield 46
Rome 43
Helsinki 42
Chandler 41
Desio 40
Boardman 34
São Paulo 33
London 31
Los Angeles 27
Washington 25
Amsterdam 24
Houston 22
Vienna 21
Jacksonville 19
Princeton 18
Wilmington 18
Kilburn 17
Madrid 17
Assago 16
Dearborn 16
Bologna 14
Cinisello Balsamo 14
Lappeenranta 14
Cambridge 13
Naples 13
Phoenix 13
Woodbridge 13
Mumbai 12
Guadalajara 11
Nanjing 10
Altamura 9
Aurora 9
Lawrence 9
Manila 9
Moscow 9
Paris 9
San Diego 9
Brussels 8
Carate Brianza 8
Chiswick 8
Genoa 8
Verona 8
Debrecen 7
Florence 7
Hyderabad 7
Orbassano 7
Villongo 7
Zagreb 7
Changsha 6
Council Bluffs 6
Delhi 6
Istanbul 6
Kolkata 6
Montreal 6
New Delhi 6
Prague 6
Santa Monica 6
Tel Aviv 6
Toronto 6
Brescia 5
Brugherio 5
Chengdu 5
Corsico 5
Dallas 5
Guangzhou 5
Melbourne 5
Melzo 5
Palermo 5
Rocca Canavese 5
San Jose 5
Shijiazhuang 5
Taiyuan 5
Tunis 5
Veniano 5
Bari 4
Bengaluru 4
Biratnagar 4
Catania 4
Chicago 4
Cologno Monzese 4
Como 4
Hangzhou 4
Monza 4
Munich 4
Nantes 4
Totale 6.033
Salva come PNG Salva come JPEG
Nome #
Assessing eligibility for treatment in acute myeloid leukemia in 2023 299
AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia 211
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study 169
RNA hyperediting and alternative splicing of hematopoietic cell phosphatase (PTPN6) gene in acute myeloid leukemia 160
The role of quantitative polymerase chain reaction in the management of follicular lymphoma patients 140
Impact of serial echocardiography in the management of primary cardiac lymphoma 131
KIT activating mutations: Incidence in adult and pediatric acute myeloid leukemia, and identification of an internal tandem duplication 112
Anti-CD38 monoclonal antibody impairs CD34+ mobilization and affects clonogenic potential in multiple myeloma patients 93
Current Treatment Options and the Role of Functional Status Assessment in Classical Hodgkin Lymphoma in Older Adults: A Review 92
A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study 75
Next Generation BTK Inhibitors in CLL: Evolving Challenges and New Opportunities 71
Use of Sorafenib in FLT3-Mutant Myeloid Sarcoma: A Case Report 69
Optimal Duration of CPX-351 Treatment and Best Timing for Consolidation with Allogeneic Stem Cell Transplantation: Evidence from a Large Real-World Italian Study 66
COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies 64
Advances in the understanding of molecular genetics and therapy ofRichter transformation in chronic lymphocytic leukemia 60
Tixagevimab/Cilgavimab Pre-exposure Prophylaxis in Patients with Lymphoproliferative Disorders on BTKi 59
Sabatolimab plus hypomethylating agents in previously untreated patients with higher-risk myelodysplastic syndromes (STIMULUS-MDS1): a randomised, double-blind, placebo-controlled, phase 2 trial 58
MIS-A: Beware of non-lymphoma 55
Cerebral Infectious Opportunistic Lesions in a Patient with Acute Myeloid Leukaemia: The Challenge of Diagnosis and Clinical Management 55
Primary Results of Stimulus-MDS1: A Randomized, Double-Blind, Placebo-Controlled Phase II Study of TIM-3 Inhibition with Sabatolimab Added to Hypomethylating Agents (HMAs) in Adult Patients with Higher-Risk Myelodysplastic Syndromes (MDS) 54
Communicating the diagnosis of a hematological neoplastic disease to patients’ minor children: a multicenter prospective study 53
IN ADULT ACUTE MYELOID LEUKEMIA (AML) PERIPHERAL BLOOD MEASURABLE RESIDUAL DISEASE (MRD) BY FLOW CYTOMETRY (FC) IS FEASIBLE AND IS PROGNOSTICALLY RELEVANT 53
Cordycepin (3′dA) Induces Cell Death of AC133+ Leukemia Cells via Re-Expression of WIF1 and Down-Modulation of MYC 52
How Age, Comorbidities and Concomitant Medications Influence Ibrutinib Management and Survival in Waldenstrom Macroglobulinemia 52
"Efficient Strategies for the Reuse of Surgical and FFP2/ KN95 Face Masks during the COVID-19 Pandemic: Home-Made and Ecological Choices for the Community" 51
Danazol Treatment for Thrombocytopenia in Myelodysplastic Syndromes: Can an "Old-fashioned" Drug be Effective? 51
Cost-effectiveness analysis of gemtuzumab ozogamicin for the treatment of de novo CD33-positive Acute Myeloid Leukaemia (AML) in Italy 50
Quantification of 1,3-β-d-glucan by Wako β-glucan assay for rapid exclusion of invasive fungal infections in critical patients: A diagnostic test accuracy study 49
Cytomegalovirus and Epstein-Barr Virus DNA Kinetics in Whole Blood and Plasma of Allogeneic Hematopoietic Stem Cell Transplantation Recipients 47
Occurrence of L1M Elements in Chromosomal Rearrangements Associated to Chronic Myeloid Leukemia (CML): Insights from Patient-Specific Breakpoints Characterization 47
Lymphoma’s last therapeutic option: Freeze it! 45
A novel start-loss mutation of the SH2B3 gene in a family with myeloproliferative neoplasms 45
A phase I/II study of NMS-03592088, a FLT3, KIT and CSF1R inhibitor, in patients with relapsed or refractory AML or CMML 44
Mutational Landscape of Bone Marrow CD19 and CD138 Cells in Waldenström Macroglobulinemia (WM) and IgM Monoclonal Gammopathy of Undetermined Significance (IgM MGUS) 43
Arg expression studied in normal human leukocytes and in leukemic cells by RT-PCR 43
VENETOCLAX IN MULTI-RELAPSED MANTLE CELL LYMPHOMA PATIENTS: A REAL-LIFE MULTICENTRIC EXPERIENCE 42
Myeloma’s multiple morphologies 42
Gilteritinib as Post-Transplant Maintenance for Acute Myeloid Leukemia With Internal Tandem Duplication Mutation of FLT3 42
Identification of hematopoietic progenitor cell donor characteristics predicting successful mobilization: Results of an Italian multicenter study 42
Fungal infections in hematologic neoplasms: Autopsy findings 42
Exploring the administrative burden faced by hematologists: a comprehensive study in Italy 41
Coexisting conditions and concomitant medications do not affect venetoclax management and survival in chronic lymphocytic leukemia 40
Saccharomyces cerevisiae fungemia with granulomas in the bone marrow in a patient undergoing BMT 40
SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort 40
c-kit activating mutations and mast cell proliferation in human leukemia [4] 40
Detection by polymerase chain reaction of BCR/ ABL transcripts in myeloproliferative diseases at time of diagnosis and for monitoring chronic myelogenous leukaemia patients after bone marrow transplantation 39
ELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocol 39
Multidimensional Results and Reflections on CAR-T: The Italian Evidence 39
A study of HLA class I and class II 4-digit allele level in Stevens-Johnson syndrome and toxic epidermal necrolysis 39
Intrahospital COVID-19 infection outbreak management: Keep calm and carry on 39
A phase I/IIa clinical trial of autologous hematopoietic stem cell transplantation in amyotrophic lateral sclerosis 38
Should Patients with Waldenström Macroglobulinemia Receive a BTK Inhibitor as Frontline Therapy? 38
C-Kit point mutations in core binding factor leukemias: correlation with white blood cell count and the white blood cell index 38
Fasting and Diet: Overview in Chronic Lymphocytic Leukemia 38
A Nine-Gene Expression Signature Distinguished a Patient with Chronic Lymphocytic Leukemia Who Underwent Prolonged Periodic Fasting 38
Progressive Down Regulation of JAK-STAT, Cell Cycle, and ABC Transporter Genes in CD34+/Lin- Cells of Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients at Diagnosis Vs. 12 Months of Nilotinib Treatment Vs. Healthy Subjects 38
ACUTE PROMYELOCYTIC LEUKEMIA - COMPLETE REMISSION AND BONE-MARROW TRANSPLANTATION FOLLOW-UP MONITORED BY POLYMERASE CHAIN-REACTION 38
Prognostic significance of CD33, CD34 and CD117 expression on bone marrow blasts of patients with Myelodysplastic syndromes 38
Clinical management of peripherally inserted central catheters compared to conventional central venous catheters in patients with hematological malignancies: A large multicenter study of the REL GROUP (Rete Ematologica Lombarda - Lombardy Hematologic Network, Italy) 38
Dual antiviral therapy in haematological patients with protracted SARS-CoV-2 infection 38
LABNET AML: AN EFFICIENT NETWORK THAT CONNECTS HEMATOLOGY CENTERS AND LABORATORIES FOR A HIGH-LEVEL DIAGNOSTIC/PROGNOSTIC WORKUP OF AML 38
CLINICAL RELEVANCE OF RECURRENT ALLELE-SPECIFIC RECOMBINATION EXPRESSING THE WNT10BIVS1 ALLELE VARIANT IN ACUTE MYELOID LEUKEMIA 38
Use of Plerixafor in Poor Mobilizer Patients with Myeloma and Lymphoma: Clonogenic Capacity and Engraftment Data 37
Treatment of elderly patients with acute promyelocytic leukemia: A real life experience of the “rete ematologica lombarda” 37
Tregs and GvHD prevention by extracorporeal photopheresis: observations from a clinical trial 36
Secondary acute myeloid leukaemia in elderly patients: Patient's fitness criteria and ELN prognostic stratification can be applied to guide treatment decisions. An analysis of 280 patients by the network rete ematologica lombarda (REL) 36
Real World Outcome of Unfit Patients with Acute Myeloid Leukemia Treated with the Combination Venetoclax Plus Hypomethylating Agents in the Gimema AML2320 Observational Trial 36
Response of steroid-refractory chronic graft-versus-host disease to extracorporeal photopheresis correlates with the dose of CD3+ lymphocytes harvested during early treatment cycles 35
Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913 35
Clinical characteristics and risk factors for mortality in hematologic patients affected by COVID-19 35
Adapting the Fitness Criteria for Non-Intensive Treatments in Older Patients with Acute Myeloid Leukemia to the Use of Venetoclax-Hypomethylating Agents Combination.—Practical Considerations from the Real-Life Experience of the Hematologists of the Rete Ematologica Lombarda 35
Predicting the probability of Gaucher disease in subjects with splenomegaly and thrombocytopenia 35
IDENTIFICAZIONE DI MIRNA E GENI TARGET NELL’ANALISI TRASCRITTOMICA DELLE CELLULE CD34+/LIN- DI PAZIENTI CON LEUCEMIA MIELOIDE CRONICA IN FASE CRONICA DOPO 12 MESI DI TERAPIA CON NILOTINIB 35
High dose etoposide and cyclophosphamide (HD-VP/CTX) as salvage treatment for all patients 35
PML/RAR alpha transcripts monitored by polymerase chain reaction in acute promyelocytic leukemia during complete remission, relapse and after bone marrow transplantation 34
Plasma cell-directed therapy and anti-HLA antibody production: A successful combination? 34
Danazol Treatment for Thrombocytopenia in Lower-Risk Myelodysplastic Syndromes: A Pilot Real Life Experience 34
PROGNOSTIC CORRELATION OF CELL-OF-ORIGIN AND MYC, BCL-2 AND BCL-6 STATUS IN HIV-ASSOCIATED DIFFUSE LARGE B-CELL LYMPHOMAS 34
Successful CD34+ cell mobilization by intermediate-dose Ara-C in chronic lymphocytic leukemia patients treated with sequential fludarabine and Campath-1H 34
Imatinib mesylate in the treatment of Core Binding Factor leukemias with KIT mutations. A report of three cases 34
Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial 33
Prognostic impact of C-KIT mutations in Core Binding Factor-Leukemia 33
A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and non-toxic treatment for advanced follicular and mantle cell lymphoma 33
Identification of genes differently expressed between bone marrow CD34+/LIN-cells of patients with chronic-phase chronic myeloid leukemia at diagnosis vs 12 months of first-line nilotinib treatment 33
Outcome of Transformed Marginal Zone Lymphomas Treated in the Rituximab Era 33
Hypoplasia of the Spleen: Rare and Puzzling 33
Gastrointestinal Kaposi's Sarcoma in a Woman with Selective IgA Deficiency and prior Immunosuppressive therapy for Idiopathic Thrombocitopenioc Purpura 33
Validation of the "fitness criteria" for the treatment of older patients with acute myeloid leukemia: A multicenter study on a series of 699 patients by the Network Rete Ematologica Lombarda (REL) 33
Detection of c-KIT antigen (CD117) and c-kit mRNA in acute leukemia 33
RISK-ADAPTED, MRD-DIRECTED THERAPY FOR YOUNG ADULTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: RESULTS OF THE AML1310 TRIAL OF THE GIMEMA GROUP 32
Prevalence and prognostic impact of KIT mutations in acute myeloid leukaemia with INV(16) 32
Ibrutinib and its use in the treatment o chronic lymphocytic leukemia 32
Nilotinib interferes with cell cycle, ABC transporters and JAK-STAT signaling pathway in CD34+/lin- cells of patients with chronic phase chronic myeloid leukemia after 12 months of treatment 32
Clofarabine-based chemotherapy as a bridge to transplant in the setting of refractory or relapsed acute myeloid leukemia, after at least one previous unsuccessful salvage treatment containing fludarabine: a single institution experience 31
A PHASE II MULTI-CENTER TRIAL OF PENTOSTATIN PLUS CYCLOPHOSPHAMIDE WITH OFATUMUMAB (PCO) IN OLDER PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS 31
Prospective clinical study on extracorporeal photopheresis (ECP) as prophylaxis for chronic Graft Versus Host Disease (cGVHD) prophylaxis: an interim analysis 31
A Case of Blastic Plasmacytoid Dendritic Cell Neoplasm Extensively Studied by Flow Cytometry and Immunohistochemistry 31
Mutational Landscape of Bone Marrow CD19 and CD138 Cells in Waldenström Macroglobulinemia (WM) and IgM Monoclonal Gammopathy of Undetermined Significance (IgM MGUS) 31
Duvelisib: A new phosphoinositide-3-kinase inhibitor in chronic lymphocytic leukemia 31
Quantification of BCR/ABL transcript in mobilized cells of CML patients 31
Totale 5.153
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.923
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.923
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202019 0 0 0 0 0 0 0 0 8 4 4 3
2020/2021141 3 3 40 14 15 11 12 12 14 6 3 8
2021/2022121 6 3 15 7 11 10 2 14 7 8 12 26
2022/20231.417 27 57 11 13 9 26 0 151 58 921 64 80
2023/20243.794 57 115 139 106 515 840 653 200 657 104 76 332
2024/20254.908 545 1.184 457 439 783 295 687 221 297 0 0 0
Totale 10.591